SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omega Protein Corporation - OME

NEW YORK, March 2, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Omega Protein Corporation ("Omega" or the "Company") (NYSE: OME).   Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Omega and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

[Click here to join a class action]

On March 1, 2017, post-market, Omega disclosed that the Company had received a subpoena from the U.S. Securities and Exchange Commission seeking information in connection with an investigation of an Omega subsidiary's compliance with its probation terms and the Company's protection of whistleblower employees. 

On this news, Omega's share price has fallen as much as $5.86, or 22.32%, during intraday trading on March 2, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-omega-protein-corporation--ome-300417137.html

SOURCE Pomerantz LLP